NEW YORK – The methylation profiles of circulating tumor DNA may help diagnose colorectal cancer as well as predict patient prognosis, findings that may form the basis of a new cancer test.
Early detection of colorectal cancer helps improve patients' survival, but colonoscopy-based screening is invasive, time-consuming, and expensive, all of which may adversely influence patient compliance.
Also in Industry News
CDC Coronavirus Testing Decision Likely to Haunt US for Months to Come
Cannabidiol helps fight antibiotic-resistant bacteria
Changes in surface sugarlike molecules help cancer cells to spread